Elicio Therapeutics Inc.
ELTX | NASDAQ
$1.91
+$0.02 (+1.06%)
At close: Sep 21, 2026, 4:00 PM ET
$1.93
+$0.02 (+1.05%)
Pre-market:
Sep 22, 2026, 7:41 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.65M | 27.59M | 29.05M | 29.59M | 27.94M | 2.46M | 1.83M | 2.02M |
Cost of Revenue | 289K | 289K | 278K | 583K | 873K | 1.17M | 1.18M | 1.16M | 869K | 576K | 286K | 294K | 294K | 294K | 522K | 884K | 1.1M | 1.31M | 1.08M | 695K | 967K | 1.26M |
Gross Profit | -289K | -289K | -278K | -583K | -873K | -1.17M | -1.18M | -1.16M | -869K | -576K | -286K | -294K | -294K | -294K | 1.13M | 26.71M | 27.95M | 28.28M | 26.86M | 1.76M | 859K | 751K |
Operating Income | -37.92M | -37.58M | -37.71M | -42.35M | -44.65M | -45.48M | -44.99M | -40.9M | -41.33M | -38.18M | -35.75M | -32.31M | -27.31M | -25.77M | -32.45M | -11.85M | -21.84M | -33.85M | -25.56M | -54.04M | -49.87M | -48.9M |
Interest Income | 693K | 723K | 776K | 882K | 868K | 837K | 777K | 547K | 608K | 510K | 370K | 349.83K | 113.83K | 74.83K | 1.43M | 2.25M | 2.35M | 2.47M | 1.11M | 235.8K | 125.8K | 1.8K |
Pretax Income | -37.84M | -40.19M | -39.57M | -45.86M | -54.61M | -51.28M | -51.9M | -46.84M | -38.66M | -38.99M | -35.2M | -32.9M | -29.44M | -29.18M | -35.39M | -13.85M | -22.35M | -32.13M | -24.08M | -67.84M | -69.81M | -73.08M |
Net Income | -37.84M | -40.19M | -39.57M | -45.86M | -54.61M | -51.28M | -51.9M | -46.84M | -38.66M | -38.99M | -35.2M | -32.9M | -29.44M | -29.18M | -35.39M | -13.85M | -22.35M | -32.13M | -24.08M | -67.84M | -69.81M | -73.08M |
Selling & General & Admin | 14.23M | 13.7M | 12.81M | 11.6M | 11.73M | 11.39M | 11.11M | 11.8M | 12.17M | 12.26M | 11.9M | 10.33M | 8M | 6.36M | 8.31M | 10.65M | 13.22M | 16.19M | 13.55M | 12.52M | 14.63M | 15.78M |
Research & Development | 23.64M | 23.84M | 24.9M | 30.45M | 32.62M | 33.79M | 33.57M | 29.1M | 29.16M | 25.92M | 23.85M | 21.69M | 19.02M | 19.11M | 25.27M | 27.91M | 36.57M | 45.95M | 38.87M | 43.29M | 36.1M | 33.86M |
Other Expenses | -243K | -243K | -278K | -278K | -568K | -861K | -873K | -1.16M | -869K | -576K | -286K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 37.63M | 37.29M | 37.44M | 41.77M | 43.77M | 44.31M | 43.81M | 39.74M | 40.46M | 37.61M | 35.46M | 32.02M | 27.02M | 25.47M | 33.57M | 38.56M | 49.79M | 62.14M | 52.42M | 55.81M | 50.73M | 49.65M |
Interest Expense | 760K | 1.36M | 1.13M | 1.03M | 741K | 596K | 456K | 224K | 88K | 753K | 1.06M | 1.15M | 2.22M | 2.58M | 2.24M | 2.15M | 1.07M | n/a | n/a | 5.6M | 8.18M | 8.67M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.68M | 5.6M | 5.6M | 5.6M | 2.92M | n/a | n/a | n/a |
Cost & Expenses | 27.49M | 37.58M | 37.71M | 42.35M | 44.65M | 45.48M | 44.99M | 40.9M | 41.33M | 38.18M | 35.75M | 32.31M | 27.31M | 25.77M | 34.1M | 39.44M | 50.89M | 63.44M | 53.5M | 56.5M | 51.7M | 50.91M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 19.24M | 18.21M | 15.31M | 16.69M | 16.06M | 12.95M | 12.2M | 13.58M | 11.28M | 10.27M | 9.6M | 4.08M | 3.1M | 3.2M | 3.1M | 3.18M | 3.09M | 3M | 3M | 2.98M | 2.97M | 13.31M |
Shares Outstanding (Diluted) | 19.24M | 18.21M | 15.31M | 16.69M | 16.06M | 12.95M | 12.2M | 13.58M | 11.28M | 10.27M | 9.6M | 4.08M | 3.1M | 3.2M | 3.1M | 3.18M | 3.09M | 3M | 3M | 2.98M | 2.97M | 13.31M |
EPS (Basic) | -2.13 | -2.36 | -2.58 | -3.28 | -4.07 | -4.05 | -4.33 | -4.11 | -5.33 | -7.13 | -8.49 | -9.71 | -9.37 | -9.30 | -11.54 | -4.42 | -7.41 | -10.79 | -6.51 | -15.35 | -12.46 | -9.43 |
EPS (Diluted) | -2.13 | -2.36 | -2.58 | -3.28 | -4.07 | -4.05 | -4.33 | -4.11 | -5.33 | -7.13 | -8.49 | -9.71 | -9.37 | -9.30 | -11.54 | -4.42 | -7.41 | -10.79 | -6.51 | -15.35 | -12.46 | -9.43 |
EBITDA | -38.03M | -37.68M | -37.31M | -43.68M | -52.72M | -49.52M | -50.26M | -45.46M | -37.43M | -36.89M | -32.97M | -30.57M | -26.02M | -25.8M | -32.23M | -10.85M | -20.57M | -31.31M | -23.43M | -61.68M | -61.08M | -63.9M |
EBIT | -28.45M | -38.82M | -38.44M | -44.83M | -53.87M | -50.68M | -51.44M | -46.62M | -38.58M | -38.24M | -34.14M | -31.75M | -27.22M | -26.6M | -33.16M | -11.7M | -21.29M | -32.13M | -24.08M | -62.24M | -61.63M | -64.41M |
Depreciation & Amortization | 858K | 1.14M | 1.13M | 1.15M | 1.15M | 1.17M | 1.18M | 1.16M | 1.14M | 1.35M | 1.17M | 1.18M | 1.2M | 803.21K | 921.21K | 850.21K | 773.21K | 874K | 698.3K | 621.3K | 545.3K | 509.3K |
Add to Watchlist
Select watchlists to add or remove ELTX